144 related articles for article (PubMed ID: 1895559)
1. [Adrenocortical scintigraphy to evaluate incidental adrenal mass (incidentaloma) discovered on computed tomography].
Tsukamoto E; Itoh K; Furudate M
Kaku Igaku; 1991 Jun; 28(6):629-34. PubMed ID: 1895559
[TBL] [Abstract][Full Text] [Related]
2. [Differential diagnosis between nonhyperfunctioning adenoma and adrenal metastasis on adrenocortical scintigraphy].
Miyake H; Nakashima A; Wakisaka M; Ueda S; Suzuki K; Ishida Y; Mori H; Maeda H; Ashizawa A; Uchida T
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):816-22. PubMed ID: 2235330
[TBL] [Abstract][Full Text] [Related]
3. [Role of adrenocortical scintigraphy in the exploration of incidentally discovered tumors].
Delemer B; Gibold C; Caron J; Liehn JC; Delisle MJ
Ann Endocrinol (Paris); 1992; 53(4):147-52. PubMed ID: 1339063
[TBL] [Abstract][Full Text] [Related]
4. Adrenal masses in oncologic patients: functional and morphologic evaluation.
Francis IR; Smid A; Gross MD; Shapiro B; Naylor B; Glazer GM
Radiology; 1988 Feb; 166(2):353-6. PubMed ID: 3336710
[TBL] [Abstract][Full Text] [Related]
5. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
6. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
[TBL] [Abstract][Full Text] [Related]
7. Adrenal scintigraphy using 123I labeled 6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-123I).
Kamoi I; Oshiumi Y; Tateno Y; Shishido F; Ido T; Suzuki K; Irie T; Fukushi K; Nakayama C; Matsuura K; Itoh T; Ogawa H; Maeda M; Kojima M
Kaku Igaku; 1980 May; 17(4):389-93. PubMed ID: 7401398
[No Abstract] [Full Text] [Related]
8. Clinical significance of the solitary functioning adrenal gland.
Gross MD; Shapiro B; Freitas JE; Meyers L; Francis I; Thompson NW; Wortsman J
J Nucl Med; 1991 Oct; 32(10):1882-7. PubMed ID: 1919725
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphy of incidentally discovered bilateral adrenal masses.
Gross MD; Shapiro B; Francis IR; Bree RL; Korobkin M; McLeod MK; Thompson NW; Sanfield JA
Eur J Nucl Med; 1995 Apr; 22(4):315-21. PubMed ID: 7607261
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of adrenal scintigraphy and computed tomography (author's transl)].
Ishimaru J; Nishikawa J; Tasaka A; Machida K
Rinsho Hoshasen; 1981 May; 26(5):575-81. PubMed ID: 7277759
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of scintigraphy and tumor biopsy for incidentally detected adrenal masses].
Ochiai A; Inui E; Ukimura O; Kojima M; Watanabe H
Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):807-14. PubMed ID: 9364847
[TBL] [Abstract][Full Text] [Related]
13. Functional and scintigraphic evaluation of the silent adrenal mass.
Gross MD; Wilton GP; Shapiro B; Cho K; Samuels BI; Bouffard JA; Glazer G; Grekin RJ; Brady T
J Nucl Med; 1987 Sep; 28(9):1401-7. PubMed ID: 3625292
[TBL] [Abstract][Full Text] [Related]
14. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
[No Abstract] [Full Text] [Related]
15. [Nuclear medicine methods for the diagnosis of adrenal tumors].
Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
[No Abstract] [Full Text] [Related]
17. [Image diagnosis of adrenal disorders. III. "Nonfunctioning" adrenal adenoma, weak mineralocorticoids producing adrenal carcinoma, congenital adrenogenital syndrome due to 21-hydroxylase deficiency--simple virilizing form, and pheochromocytoma].
Yamakita N; Kikuchi M; Minamori Y; Goshima E; Murase H; Murayama M; Yasuda K; Miura K; Imaeda T; Sugiyama K
Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):677-89. PubMed ID: 2996954
[TBL] [Abstract][Full Text] [Related]
18. The value of scintigraphy and computed tomography for the differential diagnosis of primary hyperaldosteronism.
Hietakorpi S; Korhonen T; Aro A; Lampainen E; Alhava E; Karjalainen P; Wiljasalo S
Acta Endocrinol (Copenh); 1986 Sep; 113(1):118-22. PubMed ID: 3766043
[TBL] [Abstract][Full Text] [Related]
19. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
